Acura Pharmaceuticals
Acura Pharmaceuticals, Inc. Announces Notice of Issuance for Patent  more

Acura Pharmaceuticals, Inc. Secures Bridge Funding  more

BioForm Medical
Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane  more

BioForm Announces Financial Results for Quarter Ended September 30, 2007, First Quarter of Fiscal 2008  more

BioForm Strengthens Management Team with Three Leading Industry Executives  more

Bledsoe
Bledsoe Announces Partnership to Drive Growth (pdf) more

Ception Therapeutics
Ception Therapeutics Initiates Phase II/III Clinical Trial for its Lead Product Reslizumab in Eosinophilic Esophagitis (EE) in Children more

Ception Closes Year's 2nd Largest Biopharm Round (pdf) more

Ception Therapeutics Raises $63M in Series C Financing (pdf) more

Chroma Therapeutics
Chroma Announces Positive Phase I Efficacy Data For Novel Cancer Therapy CHR-2797( pdf) more

Elusys
Elusys' Anthim Dramatically Improves Survival Of Animals Treated After Active Anthrax Infection  more

Elusys Announces Collaborative Research and License Agreement with Pfizer (pdf)  more

Elusys and US Army Extend Biodefense Collaboration (pdf)  more

EUSA Pharma
EUSA: Powering to be the Next Shire?   more

EUSA Pharma Out-Licenses Preclinical-Stage Human Antibody to Glaxosmithkline for up to $44 Million Plus Royalties  more

EUSA Pharma Announces $30 Million Debt Facilty  more

EUSA Pharma Acquires Assets of Innocoll, Inc.  more

EUSA Pharma raises $175M for both the acquisition of OPi SA and further development of the Company  more

Healthcare Brands International
Healthcare Brands International Announces Acquisition of Antula Holdings AB more

Healthgrades
Healthgrades 2007 Hospital Quality Study And Ratings Released; Chasm Widens Between Best And Poor-Performing Hospitals  more

Horizon Therapeutics
Horizon Therapeutics Completes Enrollment in Phase 3 Trials for Lead Product Candidate HZT-501  more

Horizon Therapeutics Completes $30M Equity Financing  more

InSound Medical
Raves (Yes, It's True) for New Hearing Aid  more

Iomai
Iomai Wins Department of Defense Grant to Develop a Stable, Patch-based Anthrax Vaccine more

Merck to Test Iomai Patch for Boosting Vaccine Immunity  more

Iomai Awarded Government Contract, Totaling $128 Million, to Develop Dose-Sparing Patch for Use in an Influenza Pandemic  more

LifeCell
KCI to Acquire LifeCell for $1.7B in Cash, Creating a Global Medical Technology Leader  more

Millennium Pharmacy
Millennium Pharmacy Systems Completes $40M Financing  more

Revance Therapeutics
Medicis and Revance Announce Strategic Collaboration more

StrataGent
StrataGent Life Sciences, Inc. Closes $16M Series B Financing  more

Symphogen
Symphogen Issued Patent Covering Symplex™ Technology for Antibody Discovery  more

Symphogen to Present Positive Preclinical Data on Sym003 Program for RSV Infection  more

PORTFOLIO COMPANIES NEWS